Cited by 25Autism Spectrum Disorder ResearchAutoimmune Neurological Disorders and TreatmentsSystemic Lupus Erythematosus Research

Role for antibodies in altering behavior and movement

Libbey, Jane E., Fujinami, Robert S.·2010·Autism Research

Abstract

At the past meeting of INSAR, the role of autoimmunity was discussed in an educational session. This article summarizes this discussion. In immune‐mediated diseases, antibodies can contribute to the pathogenesis of the disease and are sometimes the force that drives the disease process. This concept has not been established for autism. In autoimmune diseases, such as systemic lupus erythematosus (SLE), antibodies are found to react with double‐stranded DNA. These antibodies also cross‐react with N‐methyl‐D aspartate receptors. Many SLE patients suffer neurologic syndromes of the central nervous system (CNS). Similarly individuals infected with Group A streptococcus (GAS) have antibodies against the GAS carbohydrate, which cross‐react with tubulin and lysoganglioside GM1 on neurons. During the acute stage of infection, GAS‐infected patients develop Syndenham chorea where the disease process is driven in part by these cross‐reactive antibodies. As the antibody levels decrease, the clinical features of Syndenham chorea resolve. In these two immune‐mediated diseases, antibodies clearly play a role in the pathogenesis of the diseases. There are reports that mothers of individuals with autism have antibodies that react with brain proteins and when these antibodies are passively transferred to pregnant non‐human primates or rodents the offspring has behavioral and nervous system changes. It is still not clear whether the antibodies found in mothers of individuals with autism actually play a role in the disease. More studies need to be performed to identify the proteins recognized by the antibodies and to determine how these could affect development, behavior and changes within the CNS.

Integrity signals

Registry

Crossref · 10.1002/aur.144

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Numerous studies have reported circulating anti-brain immunoglobulins in patients with ASD and in related conditions such as multiple sclerosis, schizophrenia, and systemic lupus erythematosus.

    “numerous studies have reported the presence of circulating anti-brain immunoglobulins in patients with ASD, as well as related conditions such as multiple sclerosis (Ryberg, 1982), schizophrenia (Henneberg et al, 1994), and systemic lupus erythematosus (SLE) (Libbey and Fujinami, 2010;Mackay et al, 2015;Suurmond and Diamond, 2015).”

    From The Role of the Immune System in Autism Spectrum Disorder (2017) · cites this paper as Libbey and Fujinami, 2010

  • Autoantibodies such as those described have been found in patients with other autoimmune disorders, including multiple sclerosis, schizophrenia, and SLE.

    “Autoantibodies, such as those described above, have been found in patients of other autoimmune disorders, including multiple sclerosis (Ryberg, 1982), schizophrenia (Henneberg et al, 1994), and SLE (Libbey and Fujinami, 2010).”

    From The Role of the Immune System in Autism Spectrum Disorder (2017) · cites this paper as Libbey and Fujinami, 2010

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Libbey, J. E., & Fujinami, R. S.
Affiliations
University of Utah (US)
Corresponding author
Fujinami, Robert S.
Venue
Autism Research
Publisher
Wiley
Published
2010-08
Volume
3
Issue
4
Pages
147-152
ISSN
  • 1939-3792 (ISSN-L)
  • 1939-3806
OpenAlex
W2015461952
Cited by
25
References
51
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2020: 2 · 2019: 2 · 2018: 1 · 2016: 4 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 3
FWCI
0.19
Type
journal article
Language
en
Open access
closed
Locations
  • Autism Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Autism Speaks (AS2728)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Neurology › Autoimmune Neurological Disorders and Treatments
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Keywords
autoimmunity, immunoglobulins, autism spectrum disorder, immune-mediated diseases, systemic lupus erythematosus, anti-dsDNA antibodies, NMDA receptor antibodies, neuropsychiatric lupus, Streptococcus pyogenes, anti-tubulin antibodies, anti-GM1 antibodies, Sydenham's chorea, maternal antibodies, passive transfer, behavior change
MeSH terms
Animals, Antibodies, Bacterial, Autoantibodies, Autoimmune Diseases, Brain, Child, Child Development Disorders, Pervasive, Child, Preschool, Chorea, Cross Reactions, Female, Humans, Infant, Infant, Newborn, Lupus Erythematosus, Systemic, Obsessive-Compulsive Disorder, Pregnancy, Risk Factors, Streptococcal Infections, Streptococcus pyogenes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review